共 65 条
[1]
Belongia E.A., Hedberg C.W., Gleich G.J., White K.E., Mayeno A.N., Et al., An investigation into the cause of the eosinophilia-myalgia syndrome associated with tryptophan use, New England Journal of Medicine, 323, pp. 357-365, (1990)
[2]
Blauvelt A., Falanga V., Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination, Archives of Dermatology, 127, pp. 1159-1166, (1991)
[3]
Boman B., L-tryptophan: a rational anti-depressant and a natural hypnotic?, Australian and New Zealand Journal of Psychiatry, 22, pp. 83-97, (1988)
[4]
Bulpitt K.J., Verity M.A., Clements P.J., Paulus H.E., Association of L-tryptophan and an illness resembling eosinophilic fasciitis: clinical and histopathologic findings in four patients with eosinophilia-myalgic syndrome, Arthritis and Rheumatism, 33, pp. 918-929, (1990)
[5]
Catton C.K., Elmer J.C., Whitehouse A.C., Clode J.B., Hustrulid R.I., Pulmonary involvement in the eosinophilia-myalgia syndrome, Chest, 99, pp. 327-329, (1991)
[6]
Eosinophilia-myalgia syndrome: New Mexico, Morbidity and Mortality Weekly Report, 38, pp. 765-767, (1989)
[7]
Eosinophilia-myalgia syndrome and L-tryptophan-containing products: New Mexico, Minnesota, Oregon, and New York, 1989, Morbidity and Mortality Weekly Report, 38, pp. 785-788, (1989)
[8]
Clinical spectrum of eosinophilia-myalgia syndrome — California, Morbidity and Mortality Weekly Report, 39, pp. 89-91, (1990)
[9]
Update: analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome, Morbidity and Mortality Weekly Report, 39, pp. 789-790, (1990)
[10]
Eosinophilia-myalgia syndrome: follow-up survey of patients: New York, 1990–1991, Morbidity and Mortality Weekly Report, 40, pp. 401-403, (1991)